|
1
|
Weijerman ME and de Winter JP: Clinical
practice. The care of children with Down syndrome. Eur J Pediatr.
169:1445–1452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vos T, Allen C, Arora M, Barber RM, Bhutta
ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ, et al: GBD
2015 disease and injury incidence and prevalence collaborators:
Global, regional, and national incidence, prevalence, and years
lived with disability for 310 diseases and injuries, 1990–2015: A
systematic analysis for the Global Burden of Disease Study 2015.
Lancet. 388:1545–1602. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ekelund CK, Jørgensen FS, Petersen OB,
Sundberg K and Tabor A: Danish fetal medicine research group:
Impact of a new national screening policy for Down's syndrome in
Denmark: Population based cohort study. BMJ. 337:a25472008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiu RW and Lo YM: Non-invasive prenatal
diagnosis by fetal nucleic acid analysis in maternal plasma: The
coming of age. Semin Fetal Neonatal Med. 16:88–93. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Angert RM, LeShane ES, Lo YM, Chan LY,
Delli-Bovi LC and Bianchi DW: Fetal cell-free plasma DNA
concentrations in maternal blood are stable 24 hours after
collection: Analysis of first- and third-trimester samples. Clin
Chem. 49:195–198. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW
and Lo YM: Predominant hematopoietic origin of cell-free DNA in
plasma and serum after sex-mismatched bone marrow transplantation.
Clin Chem. 48:421–427. 2002.PubMed/NCBI
|
|
7
|
Li B, Feng ZH, Sun H, Zhao ZH, Yang SB and
Yang P: The blood genome-wide DNA methylation analysis reveals
novel epigenetic changes in human heart failure. Eur Rev Med
Pharmacol Sci. 21:1828–1836. 2017.PubMed/NCBI
|
|
8
|
Nakamura A, Hattori M and Sakaki Y: A
novel gene isolated from human placenta located in Down syndrome
critical region on chromosome 21. DNA Res. 4:321–324. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wright A, Zhou Y, Weier JF, Caceres E,
Kapidzic M, Tabata T, Kahn M, Nash C and Fisher SJ: Trisomy 21 is
associated with variable defects in cytotrophoblast differentiation
along the invasive pathway. Am J Med Genet A. 130A:1–364. 2004.
View Article : Google Scholar
|
|
10
|
Alldred SK, Deeks JJ, Guo B, Neilson JP
and Alfirevic Z: Second trimester serum tests for Down's syndrome
screening. Cochrane Database Syst Rev. CD0099252012.PubMed/NCBI
|
|
11
|
Roper RJ and Reeves RH: Understanding the
basis for Down syndrome phenotypes. PLoS Genet. 2:e502006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN,
Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR, et al:
Plasma placental RNA allelic ratio permits noninvasive prenatal
chromosomal aneuploidy detection. Nat Med. 13:218–223. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tong YK, Ding C, Chiu RW, Gerovassili A,
Chim SS, Leung TY, Leung TN, Lau TK, Nicolaides KH and Lo YM:
Noninvasive prenatal detection of fetal trisomy 18 by epigenetic
allelic ratio analysis in maternal plasma: Theoretical and
empirical considerations. Clin Chem. 52:2194–2202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zemach A, McDaniel IE, Silva P and
Zilberman D: Genome-wide evolutionary analysis of eukaryotic DNA
methylation. Science. 328:916–919. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chim SS, Tong YK, Chiu RW, Lau TK, Leung
TN, Chan LY, Oudejans CB, Ding C and Lo YM: Detection of the
placental epigenetic signature of the maspin gene in maternal
plasma. Proc Natl Acad Sci USA. 102:pp. 14753–14758. 2005;
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu LJ and Zhang SL: Expression of RASSF1A
in epithelial ovarian cancers. Eur Rev Med Pharmacol Sci.
19:813–817. 2015.PubMed/NCBI
|
|
17
|
Chim SS, Jin S, Lee TY, Lun FM, Lee WS,
Chan LY, Jin Y, Yang N, Tong YK, Leung TY, et al: Systematic search
for placental DNA-methylation markers on chromosome 21: Toward a
maternal plasma-based epigenetic test for fetal trisomy 21. Clin
Chem. 54:500–511. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tong YK, Jin S, Chiu RW, Ding C, Chan KC,
Leung TY, Yu L, Lau TK and Lo YM: Noninvasive prenatal detection of
trisomy 21 by an epigenetic-genetic chromosome-dosage approach.
Clin Chem. 56:90–98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Korenberg JR: Down syndrome phenotypic
mapping. Prog Clin Biol Res. 373:43–52. 1991.PubMed/NCBI
|
|
20
|
Massin N, Frendo JL, Guibourdenche J,
Luton D, Giovangrandi Y, Muller F, Vidaud M and Evain-Brion D:
Defect of syncytiotrophoblast formation and human chorionic
gonadotropin expression in Down's syndrome. Placenta. 22:93–97.
2001. View Article : Google Scholar
|
